REGISTERED
on 12 Mar 2019
Last Applicant/ Owned by
1042 E. Fort Union Blvd. #133
Midvale
UT
84047
Serial Number
87453846 filed on 17th May 2017
Registration Number
5698057 registered on 12th Mar 2019
Correspondent Address
MIDVALE, UT 84047
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
LONGEVIKINE
Natural compounds and ingredients prepared from organic sources, namely, herbal extracts for medical purposes that serve as anti-inflammatories, namely, curcumin from turmeric root, immune boosters, namely, oleuropein from olive leaf, antioxidants, namely, resveratrol from red grape skins and adaptogens, namely, ginsenoside from ginseng; metformin for the treatment of type II Diabetes and rapamyci Read More
Classification Information
Class [005]
Pharmaceutical Products
Natural compounds and ingredients prepared from organic sources, namely, herbal extracts for medical purposes that serve as anti-inflammatories, namely, curcumin from turmeric root, immune boosters, namely, oleuropein from olive leaf, antioxidants, namely, resveratrol from red grape skins and adaptogens, namely, ginsenoside from ginseng; metformin for the treatment of type II Diabetes and rapamycin for the treatment of immunosuppression in kidney transplants, for certain cancers and Anti-aging
First Use Date in General
31st Aug 2015
First Use Date in Commerce
31st Aug 2015
Mark Details
Serial Number
No 87453846
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Mar 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 12th Mar 2019 | REGISTERED-PRINCIPAL REGISTER |
| 08th Feb 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 07th Feb 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 18th Jan 2019 | ASSIGNED TO LIE |
| 18th Jan 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 18th Jan 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 16th Jan 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 19th Dec 2018 | SU - NON-FINAL ACTION - WRITTEN |
| 19th Dec 2018 | NON-FINAL ACTION E-MAILED |